Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Kyle Piskel

CFO at Adaptive Biotechnologies Corp (ADPT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.6M

Reported trades

Filed Stock Type Shares Price Value Since
May 20SEC ADPTAdaptive Biotechnologies Corp Sell 3,115256,725 held (−1%) $13.04 $41K +103.1%
Mar 13SEC ADPTAdaptive Biotechnologies Corp Sell 18,672259,840 held (−7%) $13.17 $246K +101.1%
Feb 6SEC ADPTAdaptive Biotechnologies Corp Sell Plan 2,145216,637 held (−1%) $18.46 $40K +43.5%
Jan 14SEC ADPTAdaptive Biotechnologies Corp Sell Plan 4,290216,637 held (−2%) $18.00 $77K +47.2%
Dec 2SEC ADPTAdaptive Biotechnologies Corp Sell Plan 162,820216,637 held (−43%) $19.50 $3.2M +35.8%
Nov 18SEC ADPTAdaptive Biotechnologies Corp Sell 238269,343 held (−0%) $14.05 $3K +88.5%
  • Sell

    CFO Kyle Piskel sold $40K of ADPT at $18.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Kyle Piskel sold $77K of ADPT at $18.00 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Kyle Piskel sold $3.2M of ADPT at $19.50 — cuts the stake by 43%; pre-scheduled 10b5-1 plan sale.